Connecting you to content on EBSCOhost

Works by Cornfeld, Mark

Results: 6

1

A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosis.

Published in:

Pediatric Blood & Cancer, 2017, v. 64, n. 5, p. n/a, doi. 10.1002/pbc.26325

By:

Arceci, Robert J.;
Allen, Carl E.;
Dunkel, Ira J.;
Jacobsen, Eric;
Whitlock, James;
Vassallo, Robert;
Morris, Shannon R.;
Portnoy, Alison;
Reedy, Beth Ann;
Smith, Deborah A.;
Noble, Robert;
Murnane, Amy;
Cornfeld, Mark;
Rodriguez-Galindo, Carlos;
Heaney, Mark L.;
McClain, Kenneth;
Vaiselbuh, Sarah

Publication type:

Article

2

A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosis.

Published in:

2016

By:

Arceci, Robert J;
Allen, Carl E;
Dunkel, Ira J;
Jacobsen, Eric;
Whitlock, James;
Vassallo, Robert;
Morris, Shannon R;
Portnoy, Alison;
Reedy, Beth Ann;
Smith, Deborah A;
Noble, Robert;
Murnane, Amy;
Cornfeld, Mark;
Rodriguez-Galindo, Carlos;
Heaney, Mark L;
McClain, Kenneth;
Vaiselbuh, Sarah

Publication type:

journal article

3

Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 183, doi. 10.1007/s00280-014-2615-5

By:

Tolcher, Anthony;
Patnaik, Amita;
Papadopoulos, Kyriakos;
Rasco, Drew;
Becerra, Carlos;
Allred, Alicia;
Orford, Keith;
Aktan, Gursel;
Ferron-Brady, Geraldine;
Ibrahim, Nageatte;
Gauvin, Jennifer;
Motwani, Monica;
Cornfeld, Mark

Publication type:

Article

4

Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma.

Published in:

British Journal of Haematology, 2011, v. 152, n. 5, p. 579, doi. 10.1111/j.1365-2141.2010.08533.x

By:

Hunsucker, Sally A.;
Magarotto, Valeria;
Kuhn, Deborah J.;
Kornblau, Steven M.;
Wang, Michael;
Weber, Donna M.;
Thomas, Sheeba K.;
Shah, Jatin J.;
Voorhees, Peter M.;
Xie, Hong;
Cornfeld, Mark;
Nemeth, Jeffrey A.;
Orlowski, Robert Z.

Publication type:

Article

5

A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer.

Published in:

Investigational New Drugs, 2013, v. 31, n. 3, p. 669, doi. 10.1007/s10637-012-9857-z

By:

Hudes, Gary;
Tagawa, Scott;
Whang, Young;
Qi, Ming;
Qin, Xiang;
Puchalski, Thomas;
Reddy, Manjula;
Cornfeld, Mark;
Eisenberger, Mario

Publication type:

Article

6

Change in Worksite Smoking Behavior Following Cancer Risk Feedback: A Pilot Study.

Published in:

American Journal of Health Behavior, 2005, v. 29, n. 3, p. 215, doi. 10.5993/AJHB.29.3.3

By:

Schnoll, Robert A.;
Hao Wang;
Miller, Suzanne M.;
Babb, James S.;
Cornfeld, Mark J.;
Tofani, Susan Higman;
Hennigan-Peel, Teresa;
Balshem, Andrew;
Slater, Elyse;
Ross, Eric;
Boyd, C. S.;
Engstrom, Paul F.

Publication type:

Article